3202-34-4

Basic information

• Product Name: 4-(4-FLUORO-PHENOXY)-PIPERIDINE HYDROCHLORIDE
• Synonyms: 4-(4-FLUORO-PHENOXY)-PIPERIDINE HYDROCHLORIDE;4-(4-fluorophenoxy)piperidine(HCl);Piperidine, 4-(4-fluorophenoxy)-, hydrochloride (1:1)
• CAS NO: 3202-34-4
• Molecular Formula: C11H15ClFNO
• Molecular Weight: 231.69
• Mol File: 3202-34-4.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 326.1 °C at 760 mmHg
• Flash Point: 151 °C
• Appearance: /
• Storage Temp.: Inert atmosphere,Room Temperature
• CAS DataBase Reference: 4-(4-FLUORO-PHENOXY)-PIPERIDINE HYDROCHLORIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(4-FLUORO-PHENOXY)-PIPERIDINE HYDROCHLORIDE(3202-34-4)
• EPA Substance Registry System: 4-(4-FLUORO-PHENOXY)-PIPERIDINE HYDROCHLORIDE(3202-34-4)

Safety Data

• Hazard Codes: Xi
• HazardClass: IRRITANT
• Hazardous Substances Data: 3202-34-4(Hazardous Substances Data)

Usage

General Description

4-(4-Fluoro-phenoxy)-piperidine hydrochloride is a chemical compound that consists of a piperidine ring with a phenyl ring containing a fluoride atom attached to it. It is in the form of a hydrochloride salt. 4-(4-FLUORO-PHENOXY)-PIPERIDINE HYDROCHLORIDE may have applications in the field of medicinal chemistry, particularly in the development of pharmaceutical drugs. Its specific properties and potential uses would depend on the intended purpose and the specific research or development goals of the user.

InChI:InChI=1S/C11H14FNO.ClH/c12-9-1-3-10(4-2-9)14-11-5-7-13-8-6-11;/h1-4,11,13H,5-8H2;1H

Relevant articles and documents

AMINE DERIVATIVES

A compound of the formula: ???whereinX and X' are the same or different, and each represents a hydrogen atom, a fluorine atom, a chlorine atom or an amino optionally having substituents, and at least one of X and X' represents a fluorine atom, a chlorine atom or an amino optionally having substituents;R1 and R2 represent a hydrogen atom or C1-6 alkyl optionally having substituents, or R1 and R2, together with the adjacent nitrogen atom, form a nitrogen-containing heterocyclic ring optionally having substituents;Y and Q are the same or different, and each represents a bond or a spacer having a main chain of 1 to 6 atoms;... represents a single bond or a double bond;T1 and T2 are the same or different, and each represents C(R9) (R9 represents a hydrogen atom, a hydroxy or C1-6 alkyl) or N, when each of the adjacent ... is a single bond, and C when the adjacent ... is a double bond; andAr represents an aromatic group optionally having substituents, a C3-9 cycloalkyl group optionally having substituents, a 3 to 9-membered saturated heterocyclic group optionally having substituents, a hydrogen atom or a halogen atom; provided that 6-chloro-3-(R,S)-(N,N-dimethylamino)methyl-1-[3-(indol-3-yl)-2-[(R)-(4-phenylpiperazin-1-yl)carbonylamino]propanoyl]-1,2,3,4-tetrahydroquinoline; 6-chloro-3-(R,S)-(N,N-dimethylamino)methyl-1-[3-(indol-3-yl)-2-[(R)-4-(2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)piperidinocarbonylamino]propanoyl]-1,2,3,4-tetrahydroquinoline and 1-benzoyl-N-[(R)-2-[6-chloro-3-[(N,N-dimethylamino)methyl]-1,2,3,4-tetrahydroquinolin-1-yl]-1-[3-(indol-3-yl)propanoyl]-4-piperidinecarboxamide are excluded; a salt thereof or a prodrug thereof has an excellent somatostatin receptor binding inhibition action and is useful for preventing and/or treating diseases associated with somatostatin.